Ledger.Open graph →
SEC Form D · filed June 12, 2020

Athira Pharma, Inc

Offering
$90.9M
Sold
$89.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Glenna M. Mileson · Seattle, WAExecJohn M. Fluke, Jr · Seattle, WADirectorLeen Kawas · Seattle, WAExec · Director · PromoterMark M. Litton · Seattle, WAExecTadataka M. Yamada · Seattle, WADirectorJoseph W. Harding · Seattle, WADirectorRailroad Ranch Capital Management, LP · DALLAS, TXExecDouglas Stafford · Wauwatosa, WIDirectorConifer Management, L.L.C · New York, NYDirectorWalter Moos · South San Francisco, CADirectorGregory Alexander · New York, NYExec · Director · PromoterJohn Josey · South San Francisco, CAExecJoseph M. Edelman · Seattle, WADirectorChristina M. Thomson · Seattle, WAExecMarc A. Schneebaum · Madison, WIExec · Director · PromoterAndrew E. Ferrara · Madison, WIDirectorBrian F. Hegi · Dallas, TXExecWilliam P. Sims · Tomball, TXDirectorTheodore L. Ott · Atlanta, GADirectoran Arizona Limited liability company Camelback Real Estate Equity LLC · Phoenix, AZExecJoseph M. Edelman · Seattle, WADirectorChristina M. Thomson · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗